Published in Vaccine Weekly, March 24th, 2004
"Tuberculosis (TB) is one of the most challenging global health problems. Bacillus Calmette-Guerin (BCG), the only vaccine in use against TB, has not performed satisfactorily and most efforts to develop a new TB vaccine have met with little success," researchers in India report.
"In this review, without revisiting the stories of failed TB vaccines, we focus on what has prevented the development of a perfect TB vaccine and issues that need immediate attention in order to succeed," wrote Anil K. Tyagi and Aparna Khera...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly